Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease

被引：15

作者：

Biancone, L ^{[1
]}

Tosti, C ^{[1
]}

De Nigris, F ^{[1
]}

Fantini, M ^{[1
]}

Pallone, F ^{[1
]}

机构：

[1] Univ Roma Tor Vergata, Cattedra Gastroenterol, Dipartimento Med Interna, Ctr Eccellenza Studio Rischio Genom Patol Comples, Rome, Italy

来源：

GASTROENTEROLOGY | 2003年 / 125卷 / 02期

关键词：

D O I：

10.1016/S0016-5085(03)00983-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：637 / 638

页数：2

共 5 条

[1]

Bonner GF, 2001, AM J GASTROENTEROL, V96, P1306

[2]

Felder JB, 2000, AM J GASTROENTEROL, V95, P1949

[3] Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis [J].

Laine, L ;

Bombardier, C ;

Hawkey, CJ ;

Davis, B ;

Shapiro, D ;

Brett, C ;

Reicin, A .

GASTROENTEROLOGY, 2002, 123 (04) :1006-1012

[4]

Mahadevan U, 2002, AM J GASTROENTEROL, V97, P910

[5] COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice [J].

Sigthorsson, G ;

Simpson, RJ ;

Walley, M ;

Anthony, A ;

Foster, R ;

Hotz-Behoftsitz, C ;

Palizban, A ;

Pombo, J ;

Watts, J ;

Morham, SG ;

Bjarnason, I .

GASTROENTEROLOGY, 2002, 122 (07) :1913-1923

← 1 →